Search results
Cell therapy reckoning: Pivot to autoimmune leaves unmet need in oncology
FierceBiotech· 4 days agoThis story is part 2 in a four-part series about cell therapy created by the Fierce Biotech team....
Health Care Notes: Thyme Care scores venture investments
Nashville Post· 3 days agoNashville-based cancer care coordination company Thyme Care has announced it has received an...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoImmunic to Participate in Industry and Scientific Conferences in June PR Newswire NEW YORK, May 28, 2024 NEW YORK, May 28, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology ...
Uplift Encouragement Group empowers chronically ill, disabled with annual resource fair
WLTX-TV Columbia· 2 days agoUplift Encouragement Group hosts their annual resource fair for Midlands residents with chronic...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoLA JOLLA, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that
Biogen's new acquisition target reveals 'provocative' trial results - Boston Business Journal
The Business Journals· 6 days agoThe data comes from aa ongoing Phase 2 study of the drug felzartamab to treat IgA nephropathy, a...
Guest column: With FDA approval of software treatment for depression, the digital medicine...
WRAL TechWire· 3 days agoIn a watershed moment for digital health innovation, the FDA recently granted clearance to Rejoyn, a...
7 of this week's most noteworthy health stories, in case you missed them
Fox News· 1 day agoFox News Digital publishes a range of health pieces every day of the week to keep you up-to-date on...
Santiago Canyon College helps utilities technician map out a career
Orange County Register· 5 days agoTeresa Hodges recalls seeing surveying data on maps while working for the City of Carlsbad and...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days ago- New study follows completion of first-in-human Phase 1b trial in atopic dermatitis patients, in which selectION observed safety and tolerability of si-544 in the treatment of T cell autoimmunity - Recruitment is underway, with topline results
